Piramal Pharma Solutions, a contract development and manufacturing organisation, has announced an $80m investment to expand ...

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of ...

Piramal Pharma Solutions invests $80 million in Lexington facility expansion to meet growing demand in injectables market.

Piramal Pharma Solutions, is investing $80 million to expand its Lexington facility, doubling capacity by Q1 2027 to meet ...

Piramal’s global Contract Development and Manufacturing Organization plans to more than double the facility’s capacity by Q1 ...

Piramal Pharma Solutions, a unit of Indian CDMO Piramal Pharma, plans to spend $80 million to expand its sterile injectables ...

The expansion will equip the Lexington site with an additional 24,000 square feet of manufacturing space, a new lab, and ...

Piramal Pharma Solutions Inc. today announced plans to expand its current Lexington operations with a nearly $80 million ...

Piramal Pharma’s stock price rose 2% in the opening trading on September 30 after the business received an Establishment ...

In July 2024, the USFDA inspected the said facility with Zero Form - 483 observations and No Action Indicated (NAI) ...

Piramal Pharma aims to achieve $2 billion in annual revenue with a 25% operating margin by fiscal 2030, driven by its CDMO ...

Nandini Piramal has earned an MBA from Stanford University Graduate School of Business, California. She also holds a Bachelor ...